pilsicainide has been researched along with Cardiac Diseases in 2 studies
pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aiba, T | 1 |
Shimizu, W | 1 |
Hidaka, I | 1 |
Uemura, K | 1 |
Noda, T | 1 |
Zheng, C | 1 |
Kamiya, A | 1 |
Inagaki, M | 1 |
Sugimachi, M | 1 |
Sunagawa, K | 1 |
Ueyama, T | 1 |
Shimizu, A | 1 |
Yamagata, T | 1 |
Esato, M | 1 |
Ohmura, M | 1 |
Yoshiga, Y | 1 |
Kanemoto, M | 1 |
Kametani, R | 1 |
Sawa, A | 1 |
Suzuki, S | 1 |
Sugi, N | 1 |
Matsuzaki, M | 1 |
1 trial available for pilsicainide and Cardiac Diseases
Article | Year |
---|---|
Different effect of the pure Na+ channel-blocker pilsicainide on the ST-segment response in the right precordial leads in patients with normal left ventricular function.
Topics: Adult; Aged; Algorithms; Brugada Syndrome; Electrocardiography; Female; Heart Diseases; Humans; Lido | 2007 |
1 other study available for pilsicainide and Cardiac Diseases
Article | Year |
---|---|
Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study.
Topics: Action Potentials; Animals; Cardiovascular Agents; Disease Models, Animal; Dogs; Electrocardiography | 2006 |